Recent studies have proven the therapeutic viability of a different approach in treating retinal vascular diseases. Join Dr. John Kitchens, Dr. Margaret Chang, and Dr. David Chin Yee as they discuss their clinical experiences using a therapy with a novel mechanism of action in patients with nAMD and DME. And, learn how they approach managing patients with macular edema. This special episode of New Retina Radio, and its content, is supported by Genentech USA, Inc.
Podden och tillhörande omslagsbild på den här sidan tillhör Retina Today . Innehållet i podden är skapat av Retina Today och inte av, eller tillsammans med, Poddtoppen.
